Author(s):
The landscape of substance abuse is constantly evolving with the emergence of new drugs posing significant challenges to public health and treatment providers worldwide. This abstract explores current trends in emerging drugs of abuse and discusses effective treatment strategies to address this complex issue. Key trends include the proliferation of synthetic cannabinoids, designer stimulants, and new psychoactive substances (NPS), each presenting unique challenges due to rapid chemical modifications and varied potency. Prescription drug misuse remains a persistent concern, exacerbated by accessibility and misperceptions about safety Treatment strategies encompass early identification through education and awareness campaigns, comprehensive assessment for tailored interventions, and integration of harm reduction strategies such as naloxone distribution and telemedicine solutions. Collaborative efforts between healthcare providers, policymakers, and communities are essential to mitigate the impact of emerging drugs of abuse and to foster healthier outcomes for individuals and societies globally.
